Pharma: Your Brand Celebrity Spokespersons Are Worthless!
A survey developed by WP Engine and fielded by TNS found that nearly ALL consumers (96%) do NOT want to see stories about how...
Promotional Spending in 2013 of the Top 20 Big Pharma Spenders
I found an interesting table in the May 2014 issue of MM&M that presents promotional spending data for the top 20 -- based on...
Where’s the DTC Ads for Prophylactic Use of Truvada? Gilead, Support Your “Truvada Whores!”
As reported in the New York Times (see here) the Centers for Disease Control (CDC) recommended Wednesday that hundreds of thousands of Americans at...
Will FDA Avoid the “Social Media Guidance Cliff”?
Section 1121 of the Prescription Drug User Fee Act (PDUFA) states: "Not later than 2 years after the date of enactment , FDA shall...
Brand vs Corporate: A Distinction without a Difference in Social Media
"Do you want someone from corporate communications talking to your audience or should it be someone from the brand team who understands your audience...
When Big Pharma Sells Older Drugs, Is “Putting the Patient First” Devalued?
According to a Reuters article, "Leading global pharmaceutical companies have started to view their vast portfolios of older, established prescription drugs as vehicles for...
The Emerging Virtual Medical Conference: Opportunities for Pharma, HCPs and Patients
'The medical conference is dead, long live the medical conference,' is the title of a SlideShare presentation by Len Starnes (@lenstarnes), a respected digital health-care consultant. Starnes is referring to the emergence of the 'virtual' medical conference, which he believes will soon be adopted in one form or another by all medical societies. This article describes the changes occurring viz-a-viz major medical conferences and the impact this will have on the pharmaceutical industry, medical societies, healthcare professionals, and patients.
Pharma Promotional Spending in 2013: Professional Detailing, eDetailing, DTC Advertising, Professional Meetings, Journal Advertising
According to the latest Cegedim Strategic Data (CSD) Audit, the 20 pharma companies that spent the most on total promotion -- which includes traditional professional detailing, eDetailing, Direct-to-Consumer (DTC) advertising, professional meetings, and journal advertising -- spent a total of $14,784 Bn in 2013. This article analyzes data from several sources to determine how much of this is allocated to various media and channels and also looks at the trends for several channels.
Pharma Marketing News Vol. 13, No. 5: May 2014
Welcome to Volume 13, Issue #5 (May 2014) of Pharma Marketing News.
Is FDA Seeing What We’re Seeing with Its Old-School Web Browsers? Klick Health Wants...
In comments submitted to the FDA regarding recent social media guidance (read "FDA Publishes First Piece of Long-Awaited Social Media Guidance" for background), Klick...
